Novo Nordisk's oral drug Rybelsus, a version of semaglutide, has shown promising results in reducing the risk of cardiovascular events in patients with type 2 diabetes and established cardiovascular disease and/or chronic kidney disease in a late-stage study.
A recent study published in JAMA compared the effectiveness of two medications, methadone and buprenorphine/naloxone, for treating opioid use disorder, revealing that patients treated with methadone had a lower rate of treatment discontinuation over 24 months.
A recent study assessed the safety and efficacy of a wireless communication system between a leadless pacemaker and a subcutaneous implantable cardioverter-defibrillator in patients at risk for sudden cardiac death due to ventricular arrhythmias.
A recent study revealed associations between cardiometabolic index (CMI), insulin resistance (IR), prediabetes (preDM), and type 2 diabetes mellitus (T2D) in U.S. adults, showing elevated CMI is linked to a higher likelihood of developing IR, preDM, and T2D, with a plateau effect suggesting maintaining CMI at certain levels is beneficial.
Despite treating older, sicker patients and performing more non-elective surgeries, osteopathic surgeons achieved comparable 30-day mortality rates to their allopathic counterparts, with no significant differences in readmissions or length of stay.
Conexiant
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Older adults with higher BMI and better diet quality experienced a slower decline in depressive symptoms over a 4-year period, suggesting a potential protective effect.
Unrestricted hs-cTnT reporting boosted ED discharge rates by 16% while cutting hospital stays, all without increasing myocardial infarctions or invasive procedures.